Do I have low testosterone?
Understand your symptoms, hormone levels, and what lab tests reveal.
New articles delivered to your inbox. Research updates, clinic news, and practical guidance.
No spam. Unsubscribe anytime.
53 articles

How testosterone is made, what it does, and why it declines. Covers the HPG axis, free vs total T, and reference ranges.

Physical, sexual, and mental symptoms of low testosterone. Learn which signs matter most and when to get tested.

Low T in women causes fatigue, low libido, brain fog, and muscle loss. These 12 symptoms get missed — most doctors don't test for them.

The '1% per year' stat is wrong for most men — actual decline depends on 3 factors. Real rates by decade from 40+ years of study data.

Lab ranges span a 3x difference and call it all 'normal.' Age-adjusted ranges, free T context, and when low-normal still needs treatment.

When to draw blood, what to order, where to get tested, and how much it costs. Step-by-step testosterone testing guide.

How testosterone binds to SHBG and albumin, why free T is often more important, and clinical scenarios where total and free diverge.

How to calculate free testosterone from total T, SHBG, and albumin -- which equation labs use, why values differ, and what numbers actually matter on TRT.

Your doctor spent 90 seconds on your results. Here's what total T, free T, SHBG, E2, and hematocrit actually mean for your protocol.

Compare testosterone replacement therapy with natural optimization methods. Understand benefits, risks, and when each approach works best.

60-80% of PCOS women have high androgens, but total T misses the picture. How insulin drives free T up and when PCOS women actually need T therapy.

Most doctors don't test women's testosterone — even when symptoms are textbook. Complete guide: optimal ranges, cream vs injection, and what 1-5mg/day does.

HRT and TRT both involve hormones — but they target different problems. When to use which term, what's included, and why it matters for your treatment.

Women with low testosterone are 2x more likely to develop anxiety and depression. Here's the biology behind it — and what actually helps.

70% of perimenopausal women report irritability as their worst mood symptom. The estrogen-serotonin link, who HRT helps, and why SSRIs often miss.

Menopause brain fog affects 60%+ of women. Starting HRT within 10 years of menopause may protect cognition. The timing matters more than the hormones.

Up to 54% of perimenopausal women get heart palpitations. Here's what causes them, when to worry, and how HRT stops the racing-heart feeling fast.

Hot flashes hit 80% of menopausal women. HRT cuts them ~75%, SSRIs ~45%. Here's what works, what to take, and how fast it kicks in.

60% of perimenopausal women can't sleep. Progesterone 200mg at bedtime cuts wake-time 53%. Here's the dosing, labs, and fastest path to relief.

Menopause itself drives ~1.5 kg weight gain and a visceral-fat shift. HRT is weight-neutral to favorable — here's the real data and what helps.

Postmenopausal women on HRT lost 19.2% of body weight on tirzepatide vs 14% without. Mayo Clinic Lancet data, who it's for, the clinic angle.

52% of postmenopausal women develop pattern hair loss. Here's what HRT, minoxidil, and spironolactone actually do, and the protocol that works.

Women lose 30% of skin collagen in the first 5 years after menopause. How HRT rebuilds dermal collagen, who benefits, and what topical skincare cannot fix.

Perimenopause lasts 4-10 years. Here are the 34 symptoms most women miss, the STRAW stages, and when HRT helps the most.

Test on days 3-7 of your cycle or results are wrong. Which panels to order, optimal vs normal ranges, and how to read your results.

71% of menopausal women get joint pain. New data shows testosterone protects cartilage, prevents muscle loss, and reduces arthralgia severity.

Women lose up to 20% of bone density in the 5-7 years after menopause. HRT cuts fracture risk 24-34%. When to start, DEXA timing, and what the data shows.

Estrogen-only HRT cuts breast cancer mortality 40%. Combination HRT adds 1 case per 50-200 women. The real numbers behind the WHI scare.

The TRAVERSE trial studied 5,246 men on TRT for cardiovascular safety. Here's what the landmark study found and why the FDA removed its heart warning.

The 1941 study that linked testosterone to prostate cancer was based on one patient. Here's what 80+ years of research actually shows.

A 2026 MD Anderson study found low testosterone raised the odds of high-grade prostate cancer progression on active surveillance by 61 percent.

Does TRT cause sleep apnea? The evidence is more nuanced than guidelines suggest. Learn who's at risk and how to monitor.

An FDA panel recommends removing testosterone's Schedule III status and expanding access to age-related low T. Here's what changes and what to do now.

On April 16, 2026, the FDA asked TRT manufacturers to seek approval for low libido in idiopathic hypogonadism. Here's what it means for patients now.

Testosterone is trending across media. Here's who qualifies for TRT, who should fix lifestyle first, and what the FDA actually changed.

On April 30, 2026, Acrux announced Phase 3 trials for a transdermal female testosterone product for HSDD. Here is what it means and what is available now.

A new 2026 cohort tracked 9,537 men on TRT for up to a year. Here's what the data says about hematocrit, libido, and who runs into trouble.

A new 2026 meta-analysis pooled 41 RCTs and 11,161 men. Here's what it actually says about TRT, heart attacks, strokes, and prostate cancer.

Europe's testosterone expert panel issued its 2026 TRAVERSE verdict. Heart attacks reassuring, atrial fibrillation signal real. What changes for you.

A 2026 NHANES analysis using gold-standard testosterone testing names diabetes, obesity, and isolation as the real drivers of low T in American men.

The FDA removed black box warnings from HRT products in 2025. Prescriptions surged 184%. Here's what the science says and what to do next.

FDA approved the first generic conjugated estrogens in 30+ years. Prices, pharmacy availability, and whether to switch from brand Premarin.

A 2026 AAOS study of 13,000+ patients links pre-surgery TRT to higher infection, clot, and complication rates. What to tell your surgeon.

A 2026 analysis links TRT to a 3-fold higher risk of shoulder fractures, echoing the TRAVERSE substudy. What it means for older men on testosterone.

March 2026 JAMA study: high p-tau217 plus combined HRT linked to 4x dementia risk. What it means if you are on or considering hormone therapy.

Feb 2026 systematic review of 2,628 women on testosterone: zero cardiovascular deaths in trials. What the data actually says — and where the gaps are.

The viral TikTok hack pairs an allergy pill with an acid reducer for hot flashes. Thin science, real relief for some, real trade-offs.

Frozen shoulder hits menopausal women 4x more than men. Duke and UCSF data show HRT may cut risk dramatically. Mechanism, evidence, and treatment guide.

A May 2026 Cleveland Clinic study in Nature found men on testosterone supplements had 38% lower glioblastoma mortality. What it means for TRT users.

A May 2026 study of 332 women on individualized testosterone therapy reports 84% energy gains and 90% quality-of-life improvement. What it means for HRT.

Migraines often worsen in perimenopause. How transdermal estradiol, continuous progesterone, and the aura-stroke distinction change HRT decisions.

Why HRT started within 10 years of menopause cuts mortality 39% and CVD risk 50%, but late starts can backfire. The timing-hypothesis evidence.

Lynkuet (elinzanetant) is the first dual NK1/NK3 antagonist for menopausal hot flashes. How it works, OASIS trial data, breast cancer use, cost, and HRT comparison.